Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001415889-25-021045

Options or other derivatives

  • Chief Scientific Officer acquired 655,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kolbeck Roland Wilhelm Chief Scientific Officer 2025-08-01 Grant or award · Restricted Stock Units +145,500 145,500 D
Kolbeck Roland Wilhelm Chief Scientific Officer 2025-08-01 Grant or award · Employee Stock Option (right to buy) +510,000 510,000 D
Loading xslF345X05/form4-08052025_080841.xml…